SCHEMBL8525341

SCHEMBL8525341

O=C(O)CC(=O)Oc1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.40
TSHR P16473 1/20 0.39
ACLY P53396 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
FBP1 P09467 1/20 0.36
GPR17 Q13304 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348786 0.90 CA1 (0.41) TDP1TSHRACLYCA1CA2
SCHEMBL7950442 0.85 HSD11B1 (0.35) ACLYKDM4EL3MBTL1ALDH1A1GAA
SCHEMBL14311187 0.81 CA1 (0.35) TDP1ACLYCA1CA2CA9
SCHEMBL14305007 0.81 RAPGEF4 (0.41) TDP1TSHRKDM4ELMNAALDH1A1
SCHEMBL14554131 0.80 KDM4E (0.47) TDP1TSHRKDM4ELMNAL3MBTL1
SCHEMBL4642241 0.80 CA1 (0.39) TDP1TSHRCA1CA2CA9
SCHEMBL4642299 0.80 ALDH1A1 (0.41) TDP1TSHRCA1CA2CA9
Hydrogen Peroxide SCHEMBL29022846 0.79 CA1 (0.45) TDP1TSHRCA1CA2CA9
SCHEMBL4641646 0.78 CA1 (0.38) TDP1TSHRACLYCA1CA2
SCHEMBL7965448 0.78 ACLY (0.34) ACLYKDM4EALDH1A1GAAGPR17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227075-B Novel process for producing N, N' -bis [2- (1H-imidazol-4-yl) ethyl ] malonamide 瓦伦塔有限责任公司 2025-01-17 CN disclosed
CN-113227075-A Novel process for the production of N, N' -bis [2- (1H-imidazol-4-yl) ethyl ] malonamide 制药有限责任公司 2021-08-06 CN disclosed
CN-104349777-B Compounds for the treatment of spinal muscular atrophy PTC医疗公司 2018-05-01 CN disclosed
CN-105050598-B Novel compounds as ERK inhibitors 默沙东公司 2018-04-27 CN disclosed
CN-105555767-B Substituted oxo pyridine derivative and its purposes as factor XI, plasma thromboplastin antecedent A/ blood plasma 拜耳制药股份公司 2018-03-23 CN disclosed
CN-103319408-B For the compound of prevention and therapy cardiovascular disorder RESVERLOGIX CORP. (CA) (CA) 2016-04-13 CN disclosed
CN-105050598-A Novel compounds as ERK inhibitors MERCK SHARP & DOHME 2015-11-11 CN disclosed
CN-104349777-A Compounds for the treatment of spinal muscular atrophy PTC THERAPEUTICS INC 2015-02-11 CN disclosed
US-5985883-A FUNGICIDAL ACTIVITY AGAINST RICE BLAST DISEASE AMERICAN CYANAMID COMPANY (US) 1999-11-16 US disclosed
EP-0279298-B1 TRICYCLIC TRIAZOLOPYRIMIDINE DERIVATIVES DAIICHI SEIYAKU CO., LTD. (JP) 1992-01-15 EP disclosed
US-4898943-A Tricyclic triazolopyrimidine derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1990-02-06 US disclosed
EP-0159707-B1 TRIAZOLOPYRIMIDINE DERIVATIVES DAIICHI SEIYAKU CO., LTD. (JP) 1990-01-24 EP disclosed
EP-0279298-A1 Tricyclic triazolopyrimidine derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1988-08-24 EP disclosed
US-4652646-A ANTIALLERGENS DAIICHI SEIYAKU CO., LTD. (JP) 1987-03-24 US disclosed
EP-0159707-A2 Triazolopyrimidine derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1985-10-30 EP disclosed